GlassScriptPhysician profile
Renee R Snyder
NPI 1942281639
$4,606.72
in general payments reported to CMS, 2019-2025
31 companies · $790 in 2025
The $790 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $251 · 2021: $426 · 2022: $567 · 2023: $964 · 2024: $925 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,679.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,038.30 | 2019-2025 | Rinvoq, Skyrizi, Botox |
| Janssen Biotech, INC. | $552.32 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $441.21 | 2021-2025 | |
| Epi Health, LLC | $303.23 | 2019-2022 | |
| Pfizer INC. | $271.72 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $267.64 | 2022-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $225.44 | 2022-2025 | Dupixent, Libtayo |
| Incyte Corporation | $193.67 | 2021-2025 | Opzelura |
| Leo Pharma INC. | $168.14 | 2019-2025 | Adbry |
| Allergan, INC. | $136.57 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $130.14 | 2021-2025 | Winlevi, Absorica Ld |
| Musculoskeletal Transplant Foundation INC. | $113.90 | 2020 | |
| Amgen INC. | $109.87 | 2024-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $94.57 | 2023-2025 | Aklief, Oracea, Nemluvio |
| Ucb, INC. | $69.70 | 2024-2025 | Bimzelx |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $54.15 | 2019-2023 | Seysara |
| Lilly USA, LLC | $52.38 | 2024-2025 | Taltz, Olumiant, Ebglyss |
| Mayne Pharma Commercial LLC | $51.65 | 2019-2022 | |
| Medimetriks Pharmaceuticals, INC. | $51.32 | 2019-2022 | |
| Merz North America, INC. | $45.49 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.27 | 2019-2023 | Jublia |
| Journey Medical Corporation | $31.31 | 2019-2020 | |
| Botanix Sb INC | $26.03 | 2025 | Sofdra |
| Revance Therapeutics, INC. | $22.02 | 2024 | Daxxify |
| Cipher Pharmaceuticals US LLC | $19.93 | 2025 | Natroba, Spinosad |
| Arcutis Biotherapeutics, INC. | $19.69 | 2023 | |
| Celgene Corporation | $18.19 | 2019 | |
| Aclaris Therapeutics, INC. | $17.89 | 2019 | |
| Lnhc, INC | $17.32 | 2025 | Zelsuvmi |
| Strata Skin Sciences, INC. | $16.79 | 2023 | Xtrac |
| Dermira, INC. | $12.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.